A structure-activity relationship for induction of meningeal inflammation by muramyl peptides.
Open Access
- 1 July 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (1) , 297-302
- https://doi.org/10.1172/jci116565
Abstract
Components of bacterial peptidoglycans have potent biological activities, including adjuvant effects, cytotoxicity, and induction of sleep. Mixtures of peptidoglycan components also induce inflammation in the lung, subarachnoid space, and joint, but the structural requirements for activity are unknown. Using a rabbit model for meningitis, we determined the biological activities of 14 individual muramyl peptides constituting > 90% of the peptidoglycan of the gram-negative pediatric pathogen Haemophilus influenzae. Upon intracisternal inoculation, most of the muropeptides induced leukocytosis in cerebrospinal fluid (CSF), influx of protein into CSF, or brain edema, alone or in combination. The disaccharide-tetrapeptide, the major component of all gram-negative peptidoglycans, induced CSF leukocytosis and protein influx at doses as low as 0.4 microgram (0.42 nM). Modification of the N-acetyl muramic acid or substitution of the alanine at position four in the peptide side chain decreased leukocytosis but enhanced brain edema. As the size of the muropeptide increased, the inflammatory activity decreased. Muropeptide carrying the diaminopimelyl-diaminopimelic acid cross-link specifically induced cytotoxic brain edema. These findings significantly expand the spectrum of biological activities of natural muramyl peptides and provide the basis for a structure-activity relationship for the inflammatory properties of bacterial muropeptides.Keywords
This publication has 20 references indexed in Scilit:
- Antibiotic Therapy, Endotoxin Concentration in Cerebrospinal Fluid, and Brain Edema in Experimental Escherichia coli Meningitis in RabbitsThe Journal of Infectious Diseases, 1987
- Nonsteroidal Anti-Inflammatory Agents in the Therapy for Experimental Pneumococcal MeningitisThe Journal of Infectious Diseases, 1987
- Induction of meningeal inflammation by diverse bacterial cell wallsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Transglycosylase and endopeptidase participate in the degradation of murein during autolysis of Escherichia coliJournal of Bacteriology, 1986
- The Induction of Meningeal Inflammation by Components of the Pneumococcal Cell WallThe Journal of Infectious Diseases, 1985
- Effects of Ampicillin and Corticosteroids on Brain Water Content, Cerebrospinal Fluid Pressure, and Cerebrospinal Fluid Lactate Levels in Experimental Pneumococcal MeningitisThe Journal of Infectious Diseases, 1985
- Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cellsInfection and Immunity, 1982
- Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animalsJournal of Neurophysiology, 1975
- Effect of Probenecid on Cerebrospinal Fluid Concentrations of Penicillin and Cephalosporin DerivativesAntimicrobial Agents and Chemotherapy, 1974
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974